Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5326
Peoples Bancorp of North Carolina
PEBK
$229M
| $549K | ﹤0.01% |
15,174
+801
| +6% | +$25.8K |
|
5327
Montauk Renewables
MNTK
$270M
| $549K | ﹤0.01% |
328,662
+91,581
| +39% | +$176K |
|
|
LBRX
5328
LB Pharmaceuticals
LBRX
$997M
| $549K | ﹤0.01% |
24,641
+15,036
| +157% | +$263K |
|
5329
Princeton Bancorp
BPRN
$277M
| $548K | ﹤0.01% |
15,802
+6,042
| +62% | +$199K |
|
|
FWDI
5330
Forward Industries Inc
FWDI
$302M
| $548K | ﹤0.01% |
82,930
+81,385
| +5,268% | +$1.04M |
|
5331
Endava
DAVA
$147M
| $547K | ﹤0.01% |
86,563
+3,999
| +5% | +$30.6K |
|
5332
Sonida Senior Living
SNDA
$2.03B
| $545K | ﹤0.01% |
16,720
-10,434
| -38% | -$309K |
|
5333
iShares MSCI Japan Value ETF
EWJV
$708M
| $544K | ﹤0.01% |
13,690
+9,793
| +251% | +$388K |
|
5334
Mammoth Energy Services
TUSK
$131M
| $541K | ﹤0.01% |
292,698
+147,398
| +101% | +$297K |
|
5335
DocGo
DCGO
$62.2M
| $539K | ﹤0.01% |
614,362
-346,623
| -36% | -$370K |
|
5336
MainStreet Bancshares
MNSB
$166M
| $539K | ﹤0.01% |
26,465
+1,066
| +4% | +$20.8K |
|
5337
PrimeEnergy Resources
PNRG
$294M
| $538K | ﹤0.01% |
3,148
+498
| +19% | +$80.1K |
|
|
CPLB
5338
NYLI MacKay Core Plus Bond ETF
CPLB
$359M
| $538K | ﹤0.01% |
25,338
+25,337
| +2,533,700% | +$541K |
|
5339
Xilio Therapeutics
XLO
$59.8M
| $538K | ﹤0.01% |
59,989
-8,719
| -13% | -$91.6K |
|
5340
Nuveen Minnesota Quality Municipal Income Fund
NMS
$77.6M
| $537K | ﹤0.01% |
45,797
-14,751
| -24% | -$175K |
|
|
MRSN
5341
DELISTED
Mersana Therapeutics
MRSN
| $535K | ﹤0.01% |
18,496
-29,831
| -62% | -$567K |
|
|
NRT
5342
North European Oil Royalty Trust
NRT
$79.2M
| $535K | ﹤0.01% |
81,248
-57,962
| -42% | -$347K |
|
|
HITI
5343
High Tide
HITI
$187M
| $534K | ﹤0.01% |
201,405
+136,706
| +211% | +$406K |
|
5344
Distillate US Fundamental Stability & Value ETF
DSTL
$1.95B
| $532K | ﹤0.01% |
9,027
-2,073
| -19% | -$120K |
|
5345
NACCO Industries
NC
$353M
| $531K | ﹤0.01% |
10,833
+1,223
| +13% | +$56.2K |
|
|
MREO
5346
Mereo BioPharma
MREO
$48.2M
| $531K | ﹤0.01% |
1,273,785
-2,072,562
| -62% | -$3.95M |
|
5347
State Street Income Allocation ETF
INKM
$72M
| $531K | ﹤0.01% |
16,086
-2,403
| -13% | -$79.9K |
|
|
NBTX
5348
Nanobiotix
NBTX
$2.04B
| $530K | ﹤0.01% |
22,923
+20,545
| +864% | +$449K |
|
5349
Gran Tierra Energy
GTE
$238M
| $530K | ﹤0.01% |
124,885
+3,436
| +3% | +$14.5K |
|
|
MDV
5350
Modiv Industrial
MDV
$182M
| $529K | ﹤0.01% |
36,767
+8,040
| +28% | +$117K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.